CRISPR: Upcoming Catalysts May Validate The Bull Thesis And Force A Change In Plans (CRSP) | Old North State Wealth News
Connect with us

Investing

CRISPR: Upcoming Catalysts May Validate The Bull Thesis And Force A Change In Plans (CRSP)

Published

on

Charday Penn/E+ via Getty Images

It has been over 4 years since my last CRISPR Therapeutics (NASDAQ:CRSP) article when I was hesitant about gathering a heavy CRSP position due to the ticker’s premium valuation, volatility, and the company’s young

Read the full article here

Trending

Copyright © 2022 ONSWM News. Content posted on the Old North State Wealth News page was developed and produced by a third party news aggregation service. Old North State Wealth Management is not affiliated with the news aggregation service. The information presented is believed to be current. It should not be viewed as personalized investment advice. All expressions of opinion reflect the judgment of the authors on the date the articles were published. The information presented is not an offer to buy or sell, or a solicitation of any offer to buy or sell, any of the securities discussed.